… patients with chronic insomnia reported reductions in sleep latency and increases in total
sleep time during a 5-week nightly treatment with ramelteon. Compared to baseline, ramelteon …

… Although no differences of next-day residual effects were found between placebo and any
ramelteon dose group in our work. However, the recent study based on the healthy population …

… and withdrawal effects following discontinuation of the 5-week ramelteon treatment. These …
with chronic insomnia, in which ramelteon showed no rebound insomnia or withdrawal effects …

… tolerated without residual effects, withdrawal symptoms or rebound insomnia in the longer
… safety of long-term administration of ramelteon in Japanese patients with chronic insomnia. …

… dose–response of ramelteon in patients with chronic primary insomnia. Because cognitive
… agent, this study also assessed the effects of ramelteon in the patient groups by using visual …

… The current study evaluated the effects of ramelteon and placebo on balance, mobility, and
memory impairment after middle-of-the-night awakening in older adults with chronic insomnia…

… the efficacy of ramelteon in the treatment of chronic insomnia and suggested that ramelteon
was … Our study suggested that ramelteon was not associated with adverse effects other than …

… of ramelteon for up to 6 months in adults20,26 and older adults21,25 with chronic insomnia.
… group, the ability to interpret the effects of ramelteon on sleep from this study is limited. The …

… effects of ramelteon, an MT 1 /MT 2 melatonin receptor agonist used to treat insomnia, on
endocrine function in adults with chronic … Subjects received either ramelteon 16 mg or placebo …

… chronic insomnia, ramelteon … effects. It also generally increased total sleep time and, where
assessed, sleep efficiency. ▲ In a first-night-effect model of transient insomnia, ramelteon …